Literature DB >> 8184744

Transcriptional and post-transcriptional regulation of the human IGF-II gene expression.

J S Sussenbach1, R J Rodenburg, W Scheper, P Holthuizen.   

Abstract

The human insulin-like growth factor II (IGF-II) gene consists of nine exons and has four promoters (P1-4). The promoters exhibit a tissue-specific and developmental stage-dependent expression pattern. In fetal liver promoters P2-4 are expressed, but after birth these promoters are shut off and another promoter, P1, is activated. We have investigated some properties of the human promoters P1 and P3 and identified a number of sequence elements, that are recognized by transcription factors. Promoter P1 is stimulated by the liver-enriched transcription factors C/EBP and LAP, whereas in the proximal region of P3 we have identified several elements that are recognized by transcription factors, including krox20/egr2 and krox24/erg1. Besides transcriptional regulation of expression also regulation at the post-transcriptional level occurs. We have found that the IGF-II mRNAs are subjected to site-specific endonucleolytic cleavage yielding a labile 5' specific fragment and a stable polyadenylated 3' specific cleavage product of 1.8 kb. Two widely separated sequence elements within the last exon were identified that are able to interact and yield a double-stranded stem structure. It is likely that this structure is essential for post-transcriptional cleavage of IGF-II mRNAs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8184744     DOI: 10.1007/978-1-4615-2988-0_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

Review 1.  The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.

Authors:  H Al-Kharobi; R El-Gendy; D A Devine; J Beattie
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

Review 2.  Transcriptional regulation and biological significance of the insulin like growth factor II gene.

Authors:  W Engström; A Shokrai; K Otte; M Granérus; A Gessbo; P Bierke; A Madej; M Sjölund; A Ward
Journal:  Cell Prolif       Date:  1998 Oct-Dec       Impact factor: 6.831

3.  Switch from monoallelic to biallelic human IGF2 promoter methylation during aging and carcinogenesis.

Authors:  J P Issa; P M Vertino; C D Boehm; I F Newsham; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

Review 4.  Targeting the insulin-like growth factor pathway in hepatocellular carcinoma.

Authors:  Mónica Enguita-Germán; Puri Fortes
Journal:  World J Hepatol       Date:  2014-10-27

5.  The insulin-like growth factor 2 gene and locus in nonmammalian vertebrates: Organizational simplicity with duplication but limited divergence in fish.

Authors:  Peter Rotwein
Journal:  J Biol Chem       Date:  2018-08-28       Impact factor: 5.157

6.  PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancer.

Authors:  A Belfiore; M Genua; R Malaguarnera
Journal:  PPAR Res       Date:  2009-07-07       Impact factor: 4.964

7.  IGF-II promoter methylation and ovarian cancer prognosis.

Authors:  A C Beeghly; D Katsaros; A L Wiley; I A Rigault de la Longrais; A T Prescott; H Chen; M Puopolo; T J Rutherford; H Yu
Journal:  J Cancer Res Clin Oncol       Date:  2007-06-14       Impact factor: 4.553

8.  IGF and insulin receptor signaling in breast cancer.

Authors:  Antonino Belfiore; Francesco Frasca
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-19       Impact factor: 2.673

9.  Similarity and variation in the insulin-like growth factor 2 - H19 locus in primates.

Authors:  Peter Rotwein
Journal:  Physiol Genomics       Date:  2018-03-30       Impact factor: 3.107

10.  Cohesin is required for higher-order chromatin conformation at the imprinted IGF2-H19 locus.

Authors:  Raffaella Nativio; Kerstin S Wendt; Yoko Ito; Joanna E Huddleston; Santiago Uribe-Lewis; Kathryn Woodfine; Christel Krueger; Wolf Reik; Jan-Michael Peters; Adele Murrell
Journal:  PLoS Genet       Date:  2009-11-26       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.